Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 1 de 1
1.
Neurobiol Dis ; 195: 106498, 2024 Jun 01.
Article En | MEDLINE | ID: mdl-38583639

CHCHD10-related disease causes a spectrum of clinical presentations including mitochondrial myopathy, cardiomyopathy, amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). We generated a knock-in mouse model bearing the p.Ser59Leu (S59L) CHCHD10 variant. Chchd10S59L/+ mice have been shown to phenotypically replicate the disorders observed in patients: myopathy with mtDNA instability, cardiomyopathy and typical ALS features (protein aggregation, neuromuscular junction degeneration and spinal motor neuron loss). Here, we conducted a comprehensive behavioral, electrophysiological and neuropathological assessment of Chchd10S59L/+ mice. These animals show impaired learning and memory capacities with reduced long-term potentiation (LTP) measured at the Perforant Pathway-Dentate Gyrus (PP-DG) synapses. In the hippocampus of Chchd10S59L/+ mice, neuropathological studies show the involvement of protein aggregates, activation of the integrated stress response (ISR) and neuroinflammation in the degenerative process. These findings contribute to decipher mechanisms associated with CHCHD10 variants linking mitochondrial dysfunction and neuronal death. They also validate the Chchd10S59L/+ mice as a relevant model for FTD, which can be used for preclinical studies to test new therapeutic strategies for this devastating disease.


Disease Models, Animal , Frontotemporal Dementia , Mitochondrial Proteins , Animals , Frontotemporal Dementia/pathology , Frontotemporal Dementia/genetics , Mice , Mitochondrial Proteins/genetics , Mitochondrial Proteins/metabolism , Mice, Transgenic , Behavior, Animal/physiology , Male , Long-Term Potentiation/physiology , Mice, Inbred C57BL , Hippocampus/pathology , Hippocampus/metabolism
...